Molecular Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 42.2 | Q1 | 99.1% | 9.908 | Q1 | 99.7% |
| 2024 | 33.9 | Q1 | 99.1% | 9.263 | Q1 | 99.7% |
| 2023 | 27.7 | Q1 | 96.4% | 8.222 | Q1 | 99.6% |
| 2022 | 37.3 | Q1 | 97.1% | 8.703 | Q1 | 99.7% |
| 2021 | 41.4 | Q1 | 97.5% | 6.896 | Q1 | 99.5% |
| 2020 | — | — | 7.274 | Q1 | 99.5% | |
| 2019 | — | — | 4.581 | Q1 | 99.0% | |
| 2018 | — | — | 3.274 | Q1 | 97.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1476-4598
region
Western Europe
coverage
2002-2026